Pharma biotech firms to be poised for recovery in 2024 -
| 244460 Stock | KRW 2,215 40.00 1.77% |
About 61% of OLIPASS's investor base is looking to short. The analysis of current outlook of investing in OLIPASS suggests that many traders are alarmed regarding OLIPASS's prospects. The current market sentiment, together with OLIPASS's historical and current headlines, can help investors time the market. In addition, many technical investors use OLIPASS stock news signals to limit their universe of possible portfolio assets.
OLIPASS |
Pharma biotech firms to be poised for recovery in 2024
Read at news.google.com
 |
OLIPASS Fundamental Analysis
We analyze OLIPASS's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of OLIPASS using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of OLIPASS based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Net Income
Net Income Comparative Analysis
OLIPASS is currently under evaluation in net income category among its peers. Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
OLIPASS Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with OLIPASS stock to make a market-neutral strategy. Peer analysis of OLIPASS could also be used in its relative valuation, which is a method of valuing OLIPASS by comparing valuation metrics with similar companies.
Peers
OLIPASS Related Equities
| 011500 | Hannong Chemicals | 4.50 | ||||
| 285130 | SK Chemicals | 2.58 | ||||
| 003230 | Samyang Foods | 1.61 | ||||
| 004000 | Lotte Fine | 1.10 | ||||
| 272450 | Jin Air | 0.72 | ||||
| 005430 | Korea Air | 0.20 | ||||
| 006650 | Korea Petro | 6.00 |
Complementary Tools for OLIPASS Stock analysis
When running OLIPASS's price analysis, check to measure OLIPASS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy OLIPASS is operating at the current time. Most of OLIPASS's value examination focuses on studying past and present price action to predict the probability of OLIPASS's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move OLIPASS's price. Additionally, you may evaluate how the addition of OLIPASS to your portfolios can decrease your overall portfolio volatility.
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |